check_circleStudy Completed

Bayer Identifier:

16856

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Impact of oral PAH drugs on total healthcare costs and resource use

Trial purpose

Key Participants Requirements

Sex

N/A

Age

18 - 64 Years
  • -

  • -

Trial summary

Enrollment Goal
437
Trial Dates
January 2012 - February 2014
Phase
N/A
Could I Receive a placebo
N/A
Products
Unspecified
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
United States

Trial design

Investigating the impact of oral pulmonary arterial hypertension (PAH) drugs on total healthcare costs and resource use.
Trial Type
Observational
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here and search for websynopsis results posting